Navigation Links
Halocarbon Announces Licensing Agreement with IBM
Date:9/19/2009

Halocarbon has long produced hexafluoroisopropanol (HFIP) and has now entered into a licensing agreement with IBM to access IBM's industry-leading portfolio of patents related to hexafluoroisopropanol-based photoresists for semiconductor manufacturing.

River Edge, NJ (PRWEB) -- Halocarbon Products Corporation (www.halocarbon.com), a leading worldwide producer of specialty fluorochemicals, has entered into a licensing agreement with IBM to access IBM's industry-leading portfolio of patents related to hexafluoroisopropanol-based photoresists for semiconductor manufacturing.

"Halocarbon has long produced hexafluoroisopropanol (HFIP) as a key component in the manufacture of the anesthetic sevoflurane," said Halocarbon CEO Peter Murin. "With this agreement, we can partner our fluorochemicals development and manufacturing expertise with IBM's leadership in developing advanced electronic materials such as photoresists."

"This agreement will allow us to leverage our HFIP business and provide reliable, regular, cost-effective, US-based production of advanced photoresist compounds," added Murin.

About Halocarbon
With headquarters in River Edge, New Jersey, and a state-of-the-art manufacturing plant in North Augusta, South Carolina, USA, Halocarbon is one of the world's leading producers of specialty fluorochemicals. Halocarbon products include inert lubricants, aliphatic fluorochemicals for pharmaceutical and agricultural chemical manufacturing, inhalation anesthetics and other specialty products. For more information, please contact the company at +1-201-262-8899 or at www.halocarbon.com.

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. PDL BioPharma Announces Conversion Rate Adjustment for Its 2.00% Convertible Senior Notes Due February 15, 2012
2. AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US
3. LCA-Vision Announces CEO Resignation
4. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
5. Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock
6. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
7. Aethlon Medical, Inc. Announces Annual Meeting Results
8. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
9. Martek Announces Addition to Its Board of Directors
10. Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
11. BVGH Announces New Board Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 18, 2014 Reports from ... United States suffer from one or more chronic health ... cancer. Medication can address some of these diseases, but ... that many sufferers face. While implanted nerve stimulation devices ... the whole nerve, which can induce side effects. ...
(Date:12/19/2014)... With only 2 weeks left of ... Sartorius Biohit products . The product specials include Buy ... Pipette Trade-in Program, and free pipette tips. , Sartorius ... the world. They are ideal for lab technicians performing ... ,     Full volume range of 0.1 uL to ...
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... Houston, TX (PRWEB) December 17, 2014 ... marketing and administration for Stoller Group. In this position, ... Stoller Group, on administrative matters, develop marketing strategy and ... and services. , “Achim has tremendous knowledge and ... president of Stoller Group. “His experience and innovative thinking ...
Breaking Biology Technology:Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... Novel Proteasome Inhibitor in ... Myeloma, SOUTH SAN FRANCISCO, Calif. and NORWALK, Conn., ... Proteolix, Inc. today,announced the enrollment of the first patient ... potent and selective proteasome,inhibitor, carfilzomib (PR-171), in patients with ...
... BioVex Inc, a biotechnology,company developing clinical stage treatments ... today that it has appointed Dr. Thaddeus,Pullano, 53, ... http://www.newscom.com/cgi-bin/prnh/20070815/NYW022 ) Previously, Dr. Pullano ... Acambis from 2003 to 2007. In this role, ...
... Science Addressing Increased Demand for Food, Feed, Fuel, ... DuPont (NYSE: DD ),Chairman and CEO Charles ... Officer Thomas M. Connelly, and Group Vice President ... updated investors on DuPont,businesses serving the agriculture and ...
Cached Biology Technology:The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance 2DuPont Leaders Brief Investors on Agriculture Businesses 2DuPont Leaders Brief Investors on Agriculture Businesses 3
(Date:11/18/2014)... Nov. 18, 2014  The Secure Identity & ... today jointly announce the formation of The Airport ... its Identity and Biometric Entry and Exit ... received official support from BORDERPOL, the international non-profit ... and provide expertise regarding border security, traveler and ...
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug Association ... regulatory agencies will speak and at least seven more will ... at the Omni Shoreham Hotel in Washington D.C. ... again to have significant support from the regulatory agencies in ... Europe in our effort to help advance the ...
(Date:11/15/2014)... YORK , Nov. 13, 2014  While we may ... technology Doctor McCoy used in "Star Trek" to gain instant ... tools designed to work with smartphones and tablets for monitoring ... of the healthcare world. This may seem a tad Orwellian ... ready to adopt some of these technological opportunities into their ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... , FORT WORTH, Texas, Aug. 4 Of the ... 17. It is estimated that by 2010, human trafficking will be the ... Arthur Eisenberg, Ph.D., professor and chairman of the department of forensic and ... Identification at the University of North Texas (UNT) ...
... Lichens are the classic example of a symbiotic relationship. ... benefit from the relationship and often are unable to survive ... (The Field Museum, Chicago), Dr. James Lawrey (George Mason University, ... has put a new spin on this relationship. In ...
... nervous system integrity and axonal properties may play a key ... Rudolf Virchow Center and the Institute of Virology of the ... prion disease and suggest novel targets for therapeutic and diagnostic ... in the open-access journal PLoS Pathogens . Despite ...
Cached Biology News:DNA Helps Reunite Children With Their Families 2DNA Helps Reunite Children With Their Families 3At the fungal farmer's market, only the best cyanobacteria are for sale 2Impaired transport in neurons triggers prion disease 2
... Zyagen tissue microarrays are derived from frozen ... rigorous quality control procedures to ensure the ... manually assembled in one block, sectioned at ... coated slides. Sections are large (3-5mm in ...
... for Optimal Microdissection , CapSure HS and ... and rapid extraction of populations of pure ... with Laser Capture Microdissection., Ensure the ... Analysis , All CapSure LCM Caps have ...
... , CapSure HS and CapSure Macro LCM ... of populations of pure cells from tissue ... Microdissection., Ensure the Integrity of Microdissected ... CapSure LCM Caps have a patented transfer ...
... Microdissection (LCM) is the method of choice ... is the only instrument to offer both ... UV Laser Cutting provides ... tissues and capturing large numbers of cells. ...
Biology Products: